Day: May 6, 2021

— Vanderbilt University Medical Center (VUMC) is coordinating multiple-arm, multi-site ACTIV-4d study targeting RAAS TRV027 to be dosed in ~300 COVID-19 patients — CHESTERBROOK, Pa., May 06, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that TRV027, the Company’s novel AT1 receptor selective agonist, has been selected for an NIH ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) trial in COVID-19 patients. “The NIH’s ongoing ACTIV public-private partnership has facilitated the unprecedented development of cutting-edge vaccines and therapeutics to fight the COVID-19 pandemic. I am honored to be joining their mission as they...

– On track to present data from Phase 2b ReDUX4 trial with losmapimod in facioscapulohumeral muscular dystrophy (FSHD) at virtual FSHD International Research Congress in June 2021 – – On track to report data from Phase 1 trial in healthy adult volunteers with FTX-6058 for sickle cell disease in mid-2021 – – Conference call scheduled for 8:00 a.m. ET today – CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today provided a business update and reported financial results for the first quarter of 2021. “Fulcrum has continued to make great progress in advancing our business and progressing our pipeline in the first quarter,” said Bryan E. Stuart, president and chief...

NEW YORK and MAINZ, GERMANY, May 6, 2021— Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a Memorandum of Understanding (MoU) with the International Olympic Committee (IOC) to donate the companies’ COVID-19 vaccine to help vaccinate athletes, and their delegations, participating in the Olympic and Paralympic Games Tokyo 2020, which are scheduled to begin on July 23, 2021.  Under the MoU, the companies and the IOC will coordinate with National Olympic Committees (NOCs) around the world to understand and work to help address the local need for vaccine doses for national delegations’ participation in the Games. Delivery of initial doses to participating delegations is expected to begin at the end of May where possible with the aim to ensure participating delegations receive second doses ahead of arrivals...

HighlightsFirst-quarter revenue of $748.6 million First-quarter operating income of $26.2 million First-quarter net income of $13.4 million First-quarter adjusted EBITDA1 of $47.0 million (margin of 6.3%1 of revenue) First-quarter cash flows provided by operations of $55.4 million First-quarter net bookings of $292 million (0.4x book-to-bill); $2.7 billion for the trailing 12 months (1.0x book-to-bill) Company reiterates fiscal 2021 financial guidanceFALLS CHURCH, Va., May 06, 2021 (GLOBE NEWSWIRE) — PAE Incorporated (“PAE” or the “Company”) (NASDAQ: PAE, PAEWW) today announced first-quarter 2021 financial and operating results. CEO Commentary PAE Interim President and CEO Charlie Peiffer said, “I am very proud of the PAE team and very pleased with our operating results. We grew organic revenue about 7% over the prior year...

PLANO, Texas, May 06, 2021 (GLOBE NEWSWIRE) — Denbury Inc. (NYSE: DEN) (“Denbury” or the “Company”) today provided results for the first quarter of 2021, including the following key outcomes: FIRST QUARTER 2021 HIGHLIGHTSNet cash provided by operating activities was $53 million; Adjusted cash flow from operations(1) (non-GAAP measure) was $81 million. Development capital expenditures totaled $20 million; Free cash flow(1) (non-GAAP measure) was $59 million. Net loss totaled $70 million, or $1.38 per diluted share. Adjusted net income(1) (non-GAAP measure) was $22 million, or $0.44 per diluted share(1) (non-GAAP measure) and Adjusted EBITDAX(1) (non-GAAP measure) totaled $82 million. Total production averaged 47,357 BOE/d, consistent with expectations. Severe winter weather reduced volumes for the quarter by approximately 1,400...

– Reported Interim Data from Phase 2b ReNeu Trial of Mirdametinib in NF1-PN Demonstrating Encouraging Clinical Activity and Tolerability in the First 20 Adult Patients Enrolled – – Announced Achievement of First Patient Dosed in Allogene and Janssen Phase 1 Trials Evaluating Nirogacestat in Combination with BCMA Therapies – – Expanded Targeted Oncology Pipeline with Exclusive Worldwide License to TEAD Inhibitor Portfolio – STAMFORD, Conn., May 06, 2021 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today reported first quarter financial results for the period ended March 31, 2021 and provided an update on recent company developments. “In the first quarter of 2021 we continued...

Figure 1.Fenelon Gold, Tabasco-Cayenne-Gabbro Zones Long SectionFigure 2.Fenelon Gold, Plan ViewFigure 3.Fenelon Gold, Zoomed-In Plan View, Surface down to 250 m DepthFigure 4.Fenelon Gold, Cross Section 9975_EFigure 5.Fenelon Gold, Cross Section 10050_EFigure 6.Fenelon Gold, Cross Section 10125_ETORONTO, May 06, 2021 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX:WM) (“Wallbridge” or the “Company”) is pleased to announce that its 2021 definition and expansion drill program on the Fenelon Gold Property (“Fenelon” or the “Property”) continues to confirm the grade and geometry of the central portions of the Tabasco-Cayenne and Area 51 Zones and expand the mineralized footprint. Drilling is currently focusing on various...

GAITHERSBURG, Md., May 06, 2021 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2021 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast on Thursday, May 20, 2021 at 9:00 AM EDT.   HOW TO PARTICIPATE IN THE VIRTUAL ANNUAL MEETINGAs described in the proxy materials, stockholders of record as of the record date of March 25, 2021 are eligible to participate in and ask questions during the Virtual Annual Meeting by visiting www.virtualshareholdermeeting.com/EBS2021 and entering their 16-digit Control Number provided on the proxy card, voting instruction form or notice received from the Company to log into this website. Only one stockholder per 16-digit Control Number can access the Virtual Annual Meeting. Beneficial owners of shares held in street name will...

HOUSTON, May 06, 2021 (GLOBE NEWSWIRE) — SEACOR Marine Holdings Inc. (NYSE:SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore energy facilities worldwide, today announced results for its first quarter ended March 31, 2021. Chief Executive Officer John Gellert provided the following statement: “SEACOR Marine continues to grieve for our crew members, partners and the loved ones of those who were lost in the capsizing of the SEACOR Power. Their memories will live long in our hearts, minds and communities. We are grateful for the efforts of all those involved in our search and rescue efforts. As salvage operations continue, we remain focused on supporting our team members and their families and will keep them in our prayers.” SEACOR Marine’s consolidated operating...